Year: 2021
Type: article
Source: Nature Microbiology
Authors: Sameh S. M. Soliman, Clara Baldin, Yiyou Gu, Shakti Singh, Teclegiorgis Gebremariam, Marc Swidergall, Abdullah Alqarihi, Eman G. Youssef, Sondus Alkhazraji, Antonis Pikoulas, Christina Perske, Vivek Venkataramani, Abigail Rich, Vincent M. Bruno, Julie Dunning Hotopp, Nicolas J. Mantis, John E. Edwards, Scott G. Filler, Georgios Chamilos, Ellen S. Vitetta, Ashraf S. Ibrahim
Institutions: University of California, Los Angeles, The Lundquist Institute, UCLA Medical Center, University of Sharjah, Harbor–UCLA Medical Center, Innsbruck Medical University, Universität Innsbruck, Beni-Suef University, University of Crete, Foundation for Research and Technology Hellas, Universitätsmedizin Göttingen, University of Göttingen, Vanderbilt University, The University of Texas Southwestern Medical Center, University of Maryland, Baltimore, New York State Department of Health, Wadsworth Center
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
Funders: U.S. Department of Health and Human Services, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Vanderbilt University, University of Texas Southwestern Medical Center, National Institutes of Health, National Institute of Allergy and Infectious Diseases, National Institute of Dental and Craniofacial Research
Awards: G1045253182, G1287579924, G1780628944, Novel Candida albicans host receptors during infection and immune response, G2158307557, Novel Toxins and Receptors in Mucormycosis Pathogenesis and Treatment, G4315807140, G4657909420, G5207554480, G547777686, G5700536731, G6021656594, G6420955438, G7017958271, G7057167889, G7085510799, Therapeutic targeting of growth factor receptors to treat Mucormycosis, Humanized monoclonal antibodies to treat mucormycosis, G9000047675, G9000239325, G99112289
OpenAlex ID: W3124620674